Focused on: 

• Basic and translational research on hematopoietic regeneration
• Innovative therapies for bone marrow failure & autoimmune diseases 
• Gene therapy
• Umbilical cord blood transplantation

Clinical applications:

• Pediatric/adult hematologic malignancies
• Myelodysplastic syndromes (MDS)
• Severe aplastic anemia
• Immunodeficiency diseases

Jun Shi, M.D.

Deputy Director of the Institute/Hospital; Director, Regenerative Medicine Center; Director, Red Blood Cell Disorder Center; Deputy Director, National Clinical Research Center for Blood Diseases. 

Specializing in:

• Aplastic anemia (AA)
• Myelodysplastic syndromes (MDS)
• Hemolytic disorders, particularly relapsed/refractory autoimmune hemolytic anemia (AIHA)
• Pure red cell aplasia (PRCA) and hematopoietic dysfunction in large granular lymphocyte leukemia (LGLL)
• Isolated thrombocytopenia and isolated leukopenia
• Stem cell therapies for thalassemia

Zimin Sun, M.D.

Distinguished clinical expert; State Council Expert.

20+ years of dedicated umbilical cord blood transplantation (UCBT) practice, performed 2,000+ unrelated-donor UCBT. Specializing in clinical optimization and basic research of Hematopoietic stem cell transplantation (HSCT) and UCBT.